Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.

MLA

Leitao, Mario M., Jr, et al. “Immunohistochemical Expression of Estrogen and Progesterone Receptors and Outcomes in Patients with Newly Diagnosed Uterine Leiomyosarcoma.” Gynecologic Oncology, vol. 124, no. 3, Mar. 2012, pp. 558–62. EBSCOhost, https://doi.org/10.1016/j.ygyno.2011.11.009.

APA

Leitao, M. M., Jr, Hensley, M. L., Barakat, R. R., Aghajanian, C., Gardner, G. J., Jewell, E. L., O’Cearbhaill, R., & Soslow, R. A. (2012). Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma. Gynecologic Oncology, 124(3), 558–562. https://doi.org/10.1016/j.ygyno.2011.11.009

Chicago

Leitao, Mario M, Jr, Martee L Hensley, Richard R Barakat, Carol Aghajanian, Ginger J Gardner, Elizabeth L Jewell, Roisin O’Cearbhaill, and Robert A Soslow. 2012. “Immunohistochemical Expression of Estrogen and Progesterone Receptors and Outcomes in Patients with Newly Diagnosed Uterine Leiomyosarcoma.” Gynecologic Oncology 124 (3): 558–62. doi:10.1016/j.ygyno.2011.11.009.